Original Article Oncology
Continuous glucose monitoring and length of stay in children with asthma: A pilot feasibility study

Continuous glucose monitoring and length of stay in children with asthma: A pilot feasibility study

Authors

Leo Mueller

Leo Mueller

Mayo Clinic, Belgium

Corresponding
Aisha Rahman

Aisha Rahman

Karolinska University Hospital, French Southern Territories

Published

June 27, 2025

Paper ID

PAP-000150

Status

Published

DOI

10.65712/tmj.test000408

Continuous glucose monitoring and length of stay in children with asthma: A pilot feasibility study

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of length of stay to health systems is substantial. Methods: We conducted a pilot feasibility study across 7 centres between 2017 and 2023. Results: length of stay occurred in 18% of the intervention group versus 21% of controls. 236 participants were included (median age 54 years). Conclusion: Implementation will depend on staffing, cost and local protocols.

Introduction

The cost of length of stay to health systems is substantial. Earlier studies of continuous glucose monitoring were small or single-centre. length of stay remains a leading cause of avoidable harm among children with asthma.

Guidelines make only a weak recommendation on continuous glucose monitoring. Earlier studies of continuous glucose monitoring were small or single-centre.

Practice around continuous glucose monitoring varies widely between centres. Earlier studies of continuous glucose monitoring were small or single-centre.

Earlier studies of continuous glucose monitoring were small or single-centre. Guidelines make only a weak recommendation on continuous glucose monitoring.

Materials and Methods

The primary outcome was length of stay, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.

Eligible participants were children with asthma. Analyses were adjusted for age, sex and baseline severity. We conducted a pilot feasibility study across 7 centres between 2015 and 2023.

Results

The adjusted odds ratio was 0.72 (95% CI 0.33 to 0.94). The adjusted odds ratio was 0.84 (95% CI 0.43 to 0.94). Effects were consistent across prespecified subgroups.

GroupnEventsRate %
Centre B208215.9
Male6694832.1
Age < 65119712.9
Control4005036.8
Male504839.6
TABLE 1: Subgroup analysis
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Distribution of length of stay
Shown for children with asthma; error bars are 95% confidence intervals.

2575 participants were included (median age 77 years). length of stay occurred in 14% of the intervention group versus 22% of controls. Effects were consistent across prespecified subgroups.

Discussion

These findings suggest that continuous glucose monitoring is associated with better length of stay in children with asthma. Residual confounding cannot be excluded.

Implementation will depend on staffing, cost and local protocols.

Conclusions

Continuous glucose monitoring is a reasonable option for children with asthma to improve length of stay.

References

1. Moreau M, Andersen Q, et al. SGLT2 inhibitors and falls. N Engl J Med. 2018;20(6):18-1599.

2. Zhang F, Zhang A, et al. Early enteral nutrition and surgical site infection. Lancet. 2013;142(10):262-1222.

3. Yilmaz L, Volkov O, et al. An antibiotic stewardship programme and emergency department revisits. BMJ. 2011;145(6):322-1477.

4. Farouk B, Osei H, et al. Vitamin D supplementation and acute kidney injury. Lancet. 2010;170(9):546-1062.

5. Herrera T, Silva O, et al. Early enteral nutrition and length of stay. Lancet. 2025;350(2):808-1156.

6. Herrera C, Nakamura Z, et al. Early enteral nutrition and chronic pain scores. Lancet. 2011;77(11):178-1736.

7. Okafor H, Rahman X, et al. Home-based cardiac rehabilitation and ventilator-free days. Lancet. 2018;300(8):400-926.

8. Silva A, Volkov Y, et al. Tranexamic acid and patient satisfaction. Ann Intern Med. 2014;269(6):418-1111.

Appendices

Ethics approval: IRB-3894.